ASP1941
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Type 2 Diabetes Mellitus
Conditions
Type 2 Diabetes Mellitus
Trial Timeline
Jan 22, 2010 → Jun 26, 2010
NCT ID
NCT01302028About ASP1941
ASP1941 is a phase 1 stage product being developed by Astellas Pharma for Type 2 Diabetes Mellitus. The current trial status is completed. This product is registered under clinical trial identifier NCT01302028. Target conditions include Type 2 Diabetes Mellitus.
What happened to similar drugs?
20 of 20 similar drugs in Type 2 Diabetes Mellitus were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01972880 | Phase 1 | Completed |
| NCT01674777 | Phase 1 | Completed |
| NCT01187186 | Phase 1 | Completed |
| NCT01097681 | Phase 1 | Completed |
| NCT01302028 | Phase 1 | Completed |
| NCT01302132 | Phase 1 | Completed |
Competing Products
20 competing products in Type 2 Diabetes Mellitus